Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
Metrics | Range | Conclusion |
---|---|---|
Selected LTM EBIT Multiple | 21.7x - 24.0x | 22.9x |
Selected Fwd EBIT Multiple | 7.2x - 8.0x | 7.6x |
Fair Value | ₩13,692 - ₩15,453 | ₩14,572 |
Upside | -9.3% - 2.4% | -3.4% |
Benchmarks | Ticker | Full Ticker |
CLIO Cosmetics Co.,Ltd | A237880 | KOSDAQ:A237880 |
H.PIO Co., Ltd. | A357230 | KOSDAQ:A357230 |
NeoPharm CO., LTD. | A092730 | KOSDAQ:A092730 |
Able C&C Co., Ltd. | A078520 | KOSE:A078520 |
HYUNDAI BIOLAND Co.,Ltd. | A052260 | KOSDAQ:A052260 |
KOLMAR BNH Co.,Ltd. | A200130 | KOSDAQ:A200130 |
- | - | - |
Select LTM EBIT Multiple | |||||||
Benchmark Companies | |||||||
A237880 | A357230 | A092730 | A078520 | A052260 | A200130 | ||
KOSDAQ:A237880 | KOSDAQ:A357230 | KOSDAQ:A092730 | KOSE:A078520 | KOSDAQ:A052260 | KOSDAQ:A200130 | ||
Historical EBIT Growth | |||||||
5Y CAGR | 5.8% | -4.0% | 1.4% | 60.8% | 2.5% | -19.8% | |
3Y CAGR | 21.0% | -29.6% | 3.2% | NM- | 15.3% | -35.5% | |
Latest Twelve Months | -53.5% | -67.2% | 2.3% | 58.4% | 11.0% | -38.2% | |
Historical EBIT Profit Margin | |||||||
5 Year Average Margin | 6.6% | 10.5% | 25.0% | -3.0% | 8.0% | 11.0% | |
Prior Fiscal Year | 10.2% | 9.4% | 26.1% | 4.2% | 13.9% | 5.2% | |
Latest Fiscal Year | 7.0% | 3.3% | 20.7% | 7.5% | 13.7% | 4.0% | |
Latest Twelve Months | 5.1% | 2.5% | 20.9% | 7.7% | 13.2% | 3.2% | |
Current Trading Multiples | |||||||
EV / LTM Revenue | 0.32x | 0.41x | 0.76x | 0.68x | 1.35x | 0.86x | |
EV / LTM EBITDA | 5.5x | 8.1x | 3.2x | 5.8x | 7.4x | 13.3x | |
EV / LTM EBIT | 6.3x | 16.5x | 3.6x | 8.8x | 10.2x | 27.3x | |
Low | Mid | High | |||||
Benchmark EV / LTM EBIT | 3.6x | 8.8x | 16.5x | ||||
Historical EV / LTM EBIT | 8.5x | 13.7x | 16.9x | ||||
Selected EV / LTM EBIT | 21.7x | 22.9x | 24.0x | ||||
(x) LTM EBIT | 18,667 | 18,667 | 18,667 | ||||
(=) Implied Enterprise Value | 406,007 | 427,376 | 448,745 | ||||
(-) Non-shareholder Claims * | (85,703) | (85,703) | (85,703) | ||||
(=) Equity Value | 320,305 | 341,673 | 363,042 | ||||
(/) Shares Outstanding | 28.3 | 28.3 | 28.3 | ||||
Implied Value Range | 11,320.21 | 12,075.43 | 12,830.65 | ||||
FX Rate: KRW/KRW | 1.0 | 1.0 | 1.0 | Market Price | |||
Implied Value Range (Trading Cur) | 11,320.21 | 12,075.43 | 12,830.65 | 15,090.00 | |||
Upside / (Downside) | -25.0% | -20.0% | -15.0% |
Equity Waterfall | |||||||
Benchmark Companies | |||||||
(in millions) | A237880 | A357230 | A092730 | A078520 | A052260 | A200130 | |
Enterprise Value | 107,904 | 98,750 | 89,199 | 175,093 | 170,212 | 512,673 | |
(+) Cash & Short Term Investments | 151,962 | 49,561 | 134,724 | 36,442 | 4,337 | 99,849 | |
(+) Investments & Other | 25,099 | 13,069 | 1,310 | 3 | 237 | 29,992 | |
(-) Debt | (1,755) | (14,592) | (468) | (12,009) | (14,586) | (217,345) | |
(-) Other Liabilities | 864 | (38,230) | 0 | 0 | 0 | 1,801 | |
(-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
(-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
Value of Common Equity | 284,074 | 108,557 | 224,765 | 199,529 | 160,200 | 426,970 | |
(/) Shares Outstanding | 17.5 | 41.3 | 15.6 | 26.0 | 30.0 | 28.3 | |
Implied Stock Price | 16,210.00 | 2,630.00 | 14,370.00 | 7,670.00 | 5,340.00 | 15,090.00 | |
FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
Implied Stock Price (Trading Cur) | 16,210.00 | 2,630.00 | 14,370.00 | 7,670.00 | 5,340.00 | 15,090.00 | |
Trading Currency | KRW | KRW | KRW | KRW | KRW | KRW | |
FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |